Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Research Into the Expression of the csgA-gene and How it Changes in Patients With Parkinson's Disease

Trial N/A Recruiting Aug. 18, 2026

The Validity and Reliability of an Improved Paper Grasping Test for Parkinson's Disease

Trial N/A Completed Aug. 18, 2026

Bracing for Walking in Parkinson's Disease

Trial N/A Completed Aug. 17, 2026

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

Trial Phase 1 Recruiting Aug. 16, 2026

Neuromodulation for Patients With Parkinson's Disease

Trial N/A Not yet recruiting Aug. 16, 2026

A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease

Trial Phase 2 Recruiting Aug. 16, 2026

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Trial N/A Recruiting Aug. 13, 2026

A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease

Trial Phase 1 Recruiting Aug. 13, 2026

Advance Care Planning and Care Coordination for People With Parkinson's Disease

Trial N/A Completed Aug. 13, 2026

Enhancement of Quality of Work And Life

Trial N/A Active, not recruiting Aug. 13, 2026

A Targeted Amino Acid Supplement for People With Parkinson's Disease

Trial Early Phase 1 Completed Aug. 12, 2026

Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fluctuations

Trial Phase 3 Recruiting Aug. 12, 2026

ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease

Trial N/A Completed Aug. 12, 2026

LIFUS For Neurological Disorders

Trial N/A Recruiting Aug. 12, 2026

Daily Amino Acid Supplementation for People With Parkinson's Disease

Trial N/A Recruiting Aug. 12, 2026

Brain Dopamine Biomarker

Trial N/A Not yet recruiting Aug. 11, 2026

Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)

Trial Early Phase 1 Recruiting Aug. 11, 2026

Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease

Trial Phase 3 Not yet recruiting Aug. 11, 2026

The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

Trial Phase 1 Recruiting Aug. 11, 2026

NAD Supplementation in Parkinson's Disease

Trial N/A Enrolling by invitation Aug. 11, 2026